OCULAR THERAPEUTIX, INC Quarterly Operating Income (Loss) in USD from Q1 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ocular Therapeutix, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2013 to Q3 2024.
  • Ocular Therapeutix, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$46M, a 139% decline year-over-year.
  • Ocular Therapeutix, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$141M, a 72.9% decline year-over-year.
  • Ocular Therapeutix, Inc annual Operating Income (Loss) for 2023 was -$82.4M, a 4.74% decline from 2022.
  • Ocular Therapeutix, Inc annual Operating Income (Loss) for 2022 was -$78.7M, a 0.79% decline from 2021.
  • Ocular Therapeutix, Inc annual Operating Income (Loss) for 2021 was -$78M, a 24.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$141M -$46M -$26.8M -139% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$114M -$43.6M -$23M -112% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$91.5M -$31.6M -$9.07M -40.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$82.4M -$20M -$688K -3.55% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 -$81.7M -$19.2M +$2.33M +10.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$84M -$20.6M -$654K -3.28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$83.4M -$22.5M -$4.72M -26.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$78.7M -$19.4M -$1.31M -7.27% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 -$77.3M -$21.5M -$2.02M -10.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$75.3M -$19.9M +$315K +1.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$75.6M -$17.8M +$2.4M +11.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$78M -$18M -$3.71M -25.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-11
Q3 2021 -$74.3M -$19.5M -$5.52M -39.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$68.8M -$20.2M -$2.35M -13.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$66.5M -$20.2M -$3.61M -21.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$62.8M -$14.3M +$7.06M +33% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 -$69.9M -$14M +$9.14M +39.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$79M -$17.9M +$3.72M +17.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$82.8M -$16.6M +$3.04M +15.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$85.8M -$21.4M -$4.12M -23.8% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$81.7M -$23.1M -$8.33M -56.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$73.4M -$21.6M -$8.04M -59.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$65.3M -$19.7M -$6.2M -46.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$59.1M -$17.3M -$4.57M -35.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$54.6M -$14.8M +$380K +2.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$54.9M -$13.6M +$4.78M +26% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$59.7M -$13.5M +$2.22M +14.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$61.9M -$12.7M -$244K -1.96% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$61.7M -$15.2M -$5.96M -64.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$55.7M -$18.3M -$7.23M -65.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$48.5M -$15.7M -$5.16M -49.1% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$43.3M -$12.5M -$2.2M -21.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$41.1M -$9.24M +$1.94M +17.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$43.1M -$11.1M -$1.47M -15.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$41.6M -$10.5M -$3.4M -47.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$38.2M -$10.3M -$2.73M -36.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-10
Q3 2015 -$35.5M -$11.2M -$4.4M -64.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-10
Q2 2015 -$31.1M -$9.64M -$3.69M -62% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-10
Q1 2015 -$27.4M -$7.11M -$288K -4.22% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-10
Q4 2014 -$27.1M -$7.55M -$4.13M -121% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-10
Q3 2014 -$23M -$6.78M -$3.34M -97.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-10
Q2 2014 -$19.6M -$5.95M -$2.96M -98.9% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-10
Q1 2014 -$16.7M -$6.83M -$3.77M -123% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-10
Q4 2013 -$12.9M -$3.42M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-20
Q3 2013 -$3.44M Jul 1, 2013 Sep 30, 2013 10-K 2015-03-20
Q2 2013 -$2.99M Apr 1, 2013 Jun 30, 2013 10-K 2015-03-20
Q1 2013 -$3.06M Jan 1, 2013 Mar 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.